P&K Skin Research Center Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 41.86%

P&K Skin Research Center Co. Ltd (347740) has an Asset Resilience Ratio of 41.86% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read P&K Skin Research Center Co. Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩35.95 Billion

≈ $24.36 Million USD Cash + Short-term Investments

Total Assets

₩85.87 Billion

≈ $58.20 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2024)

This chart shows how P&K Skin Research Center Co. Ltd's Asset Resilience Ratio has changed over time. See P&K Skin Research Center Co. Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down P&K Skin Research Center Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 347740 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩35.95 Billion	41.86%
Total Liquid Assets	₩35.95 Billion	41.86%

Asset Resilience Insights

Very High Liquidity: P&K Skin Research Center Co. Ltd maintains exceptional liquid asset reserves at 41.86% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

P&K Skin Research Center Co. Ltd Industry Peers by Asset Resilience Ratio

Compare P&K Skin Research Center Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.19%
Shanghai Labway Clinical Laboratory Co Ltd SHE:301060	Diagnostics & Research	2.10%
Genoray Co. Ltd KQ:122310	Diagnostics & Research	0.03%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Avricore Health Inc V:AVCR	Diagnostics & Research	0.75%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%

Annual Asset Resilience Ratio for P&K Skin Research Center Co. Ltd (2018–2024)

The table below shows the annual Asset Resilience Ratio data for P&K Skin Research Center Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	49.62%	₩40.71 Billion ≈ $27.59 Million	₩82.04 Billion ≈ $55.60 Million	-8.11pp
2023-12-31	57.73%	₩44.69 Billion ≈ $30.28 Million	₩77.41 Billion ≈ $52.46 Million	-19.36pp
2022-12-31	77.09%	₩57.46 Billion ≈ $38.94 Million	₩74.54 Billion ≈ $50.51 Million	+14.12pp
2021-12-31	62.97%	₩42.25 Billion ≈ $28.63 Million	₩67.09 Billion ≈ $45.47 Million	-20.05pp
2020-12-31	83.02%	₩49.72 Billion ≈ $33.70 Million	₩59.89 Billion ≈ $40.59 Million	+1.66pp
2019-12-31	81.36%	₩22.76 Billion ≈ $15.42 Million	₩27.97 Billion ≈ $18.95 Million	+16.89pp
2018-12-31	64.47%	₩11.37 Billion ≈ $7.71 Million	₩17.64 Billion ≈ $11.95 Million	--

pp = percentage points

About P&K Skin Research Center Co. Ltd

KQ:347740 Korea Diagnostics & Research

Market Cap

$48.83 Million

₩72.06 Billion KRW

Market Cap Rank

#21975 Global

#1455 in Korea

Share Price

₩2495.00

Change (1 day)

-1.77%

52-Week Range

₩1996.00 - ₩3235.00

All Time High

₩7272.32